Influenza Publications
| Jeffrey A. Linder, MD, MPH, Harry Reyes Nieva, William A. Blumentals, PhD | |||
 |
|
Antiviral and Antibiotic Prescribing for Influenza in Primary Care | |
| Antiviral and Antibiotic Prescribing for Influenza in Primary Care | |||
| Winiarski et al | |||
|
|
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules | |
| Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules | |||
| Blumentals, Song | |||
|
|
The Safety of Oseltamivir in patients with Influenza: Analysis of Healthcare Claims Data from Six Influenza Seasons | |
| The Safety of Oseltamivir in patients with Influenza: Analysis of Healthcare Claims Data from Six Influenza Seasons | |||
| Mohammad Madjid, Suellen Curkendall, William A. Blumentals | |||
|
|
The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection | |
| The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection | |||
| Peters P, Moscona A, Schulman KL, Barr CE | |||
|
|
Study of the impact of oseltamivir on the risk of pneumonia and other outcomes of influenza, 2000-2005 | |
| Study of the impact of oseltamivir on the risk of pneumonia and other outcomes of influenza, 2000-2005 | |||
| Orzeck, Nianwen, Blumentals | |||
|
|
Oseltamivir and the Risk of Influenza Related Complications and Hospitalizations in Patients with Diabetes | |
| Oseltamivir and the Risk of Influenza Related Complications and Hospitalizations in Patients with Diabetes | |||
| Gums, Pelletier, Blumentals | |||
|
|
Oseltamivir and influenza related complication, hospitalization and healthcare expenditure in health adults and children | |
| Oseltamivir and influenza related complication, hospitalization and healthcare expenditure in health adults and children | |||
| Nila J. Dharan, MD | |||
|
|
Infections with Oseltamivir-Resistant Influenza A (H1N1) Virus in the United States | |
| William A. Blumentals, Kathy L Schulman | |||
|
|
Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients | |
| Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients | |||
| Anne Moscona, MD | |||
|
|
Global Transmission of Oseltamivir-Resistant Influenza | |
